Publications:

Targeted sequencing reveals the mutational landscape responsible for sorafenib therapy in advanced hepatocellular carcinoma.

Theranostics

Tang, Jing J; Sui, Cheng-Jun CJ; Wang, Dong-Fang DF; Lu, Xin-Yuan XY; Luo, Gui-Juan GJ; Zhao, Qing Q; Lian, Qiu-Yu QY; Jeong, Seogsong S; Lin, Xi-Meng XM; Zhu, Yan-Jing YJ; Zheng, Bo B; Wu, Rui R; Wang, Qing Q; Liu, Xiao-Long XL; Liu, Jing-Feng JF; Xia, Qiang Q; Wu, Gang G; Gu, Jin J; Wang, Hong-Yang HY; Chen, Lei L

Publication Date: 2020

Variant appearance in text: NFKB1: H712H

PubMed Link: 32373219

Variant Present in the following documents:

• thnov10p5384s2.xlsx, sheet 4

View BVdb publication page

Reproducible Analysis of Post-Translational Modifications in Proteomes--Application to Human Mutations.

Plos One

Holehouse, Alex S AS; Naegle, Kristen M KM

Publication Date: 2015

Variant appearance in text: rs4648099

PubMed Link: 26659599

Variant Present in the following documents:

• pone.0144692.s002.xlsx, sheet 1

View BVdb publication page

IκBKβ and NFκB1, NSAID use and risk of colorectal cancer in the Colon Cancer Family Registry.

Carcinogenesis

Seufert, Brenna L BL; Poole, Elizabeth M EM; Whitton, John J; Xiao, Liren L; Makar, Karen W KW; Campbell, Peter T PT; Kulmacz, Richard J RJ; Baron, John A JA; Newcomb, Polly A PA; Slattery, Martha L ML; Potter, John D JD; Ulrich, Cornelia M CM

Publication Date: 2013-01

Variant appearance in text: rs4648099

PubMed Link: 23002237

Variant Present in the following documents:

• Main text

View BVdb publication page